Dengue Academy is intended for an international audience of healthcare professionals outside of the US and UK.
This website has been initiated and developed by Takeda

© Copyright 2022 Takeda Pharmaceutical Company Limited. All rights reserved.
Takeda and the Takeda Logo are registered trademarks of Takeda Pharmaceutical Company Limited.
VV-MEDMAT-55340, Date of preparation: November 2021

Dengue & COVID-19

Resources for patient support

Takeda

3 minutes
Impact of the COVID-19 Pandemic on the Global Dengue Situation

ADVA

79 minutes
Managing the severely ill dengue patients – Adult and Paediatric Intensivists

ADVA

92 minutes
Impact of SARS-CoV-2 interventions on dengue transmission

Takeda

2 minutes
Similarities and differences between 'cytokine storms’ in acute dengue and COVID-19

Takeda

2 minutes
Covid-19 and dengue: Double punches for dengue-endemic countries in Asia

Takeda

2 minutes
Experience of a tertiary hospital in Singapore managing a dual outbreak of COVID and dengue

Takeda

2 minutes
The COVID-19 pandemic should not jeopardize dengue control

Takeda

2 minutes
Dengue diagnosis: unique challenges in a time of a pandemic

Medscape

15 minutes

Dengue Academy is intended for an international audience of healthcare professionals outside of the US and UK.
This website has been initiated and developed by Takeda